Literature DB >> 3492429

Human pluripotent hemopoietic colony stimulating factor: activities on human and murine cells.

E Platzer, S Oez, K Welte, A Sendler, J L Gabrilove, R Mertelsmann, M A Moore, J R Kalden.   

Abstract

Human pluripotent colony stimulating factor (Pluripoietin) was shown to act synergistically with human pluripotent alpha-like colony-stimulating activity (Pluripoietin-alpha) supporting the proliferation and differentiation of human CFU-GM progenitor cells in vitro, increasing colony size and numbers. In addition, Pluripoietin enhanced cytotoxic activity of mature human neutrophil granulocytes in an antibody-dependent cellular cytotoxicity assay. Biological activities of Pluripoietin known so far suggest great potentials for clinical use. Preclinical in vivo studies of Pluripoietin in different disease situations may be feasible in mice, because Pluripoietin is active on granulocyte precursors and on a variety of other murine cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3492429     DOI: 10.1016/S0171-2985(86)80098-5

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  7 in total

Review 1.  Concise review: Sowing the seeds of a fruitful harvest: hematopoietic stem cell mobilization.

Authors:  Jonathan Hoggatt; Jennifer M Speth; Louis M Pelus
Journal:  Stem Cells       Date:  2013-12       Impact factor: 6.277

Review 2.  Human granulocyte colony stimulating factor.

Authors:  E Platzer; J R Kalden
Journal:  Blut       Date:  1987-03

3.  Fully Synthetic Granulocyte Colony-Stimulating Factor Enabled by Isonitrile-Mediated Coupling of Large, Side-Chain-Unprotected Peptides.

Authors:  Andrew G Roberts; Eric V Johnston; Jae-Hung Shieh; Joseph P Sondey; Ronald C Hendrickson; Malcolm A S Moore; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2015-10-01       Impact factor: 15.419

4.  Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.

Authors:  J L Gabrilove; A Jakubowski; K Fain; J Grous; H Scher; C Sternberg; A Yagoda; B Clarkson; M A Bonilla; H F Oettgen
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

5.  Clonal growth of functionally normal and deficient neutrophils from the bone marrow of a patient with variant chronic granulomatous disease. Lack of reconstitution of oxidative burst defect by G-CSF, GM-CSF, and IFN-gamma in vitro.

Authors:  S Oez; J Birkmann; J R Kalden
Journal:  Ann Hematol       Date:  1993-01       Impact factor: 3.673

Review 6.  Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia.

Authors:  Jonathan Hoggatt; Tiffany A Tate; Louis M Pelus
Journal:  Int J Nanomedicine       Date:  2015-04-01

7.  Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates.

Authors:  K Welte; M A Bonilla; A P Gillio; T C Boone; G K Potter; J L Gabrilove; M A Moore; R J O'Reilly; L M Souza
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.